Vol 74, No 7 (2016)
Letters to the Editor
Published online: 2016-07-11
Who could benefit most from treatment of acute pulmonary embolism with rivaroxaban? Commentary to the article: “Acute pulmonary embolism treatment with rivaroxaban results in a shorter duration of hospitalisation compared to standard therapy…
DOI: 10.5603/KP.2016.0104
Kardiol Pol 2016;74(7):701-702.
Abstract
Not available
